Compounds > activins

activins and Bacterial Infections

activins has been researched along with Bacterial Infections in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's1 (25.00)29.6817
2010's2 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Besson-Fournier, C; Coppin, H; Gineste, A; Gourbeyre, O; Latour, C; Martin, P; Meynard, D; Oswald, E; Roth, MP1
Ebert, S; Michel, U; Nau, R1
Clarke, IJ; de Kretser, DM; Jones, KL; Phillips, DJ; Scheerlinck, JP1
Abbakumov, VV; Bogomolova, NS; Pkhakadze, TIa; Potekhina, AD; Stepanenko, RN; Vinogradova, LN1

Reviews

1 review(s) available for activins and Bacterial Infections

ArticleYear
Role of activin in bacterial infections: a potential target for immunointervention?
    Immunotherapy, 2010, Volume: 2, Issue:5

    Topics: Activins; Animals; Anti-Inflammatory Agents; Bacterial Infections; Follistatin; Humans; Immunotherapy; Inflammation Mediators

2010

Other Studies

3 other study(ies) available for activins and Bacterial Infections

ArticleYear
Hepcidin upregulation by inflammation is independent of Smad1/5/8 signaling by activin B.
    Blood, 2017, 01-26, Volume: 129, Issue:4

    Topics: Activins; Animals; Bacterial Infections; Bone Morphogenetic Protein 6; Endotoxemia; Escherichia coli Infections; Gene Expression Regulation; Hepcidins; Inflammation; Lipopolysaccharides; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Phosphorylation; Protein Processing, Post-Translational; Pyrazoles; Pyrimidines; RNA, Messenger; Signal Transduction; Smad Proteins; Turpentine; Up-Regulation

2017
Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe.
    The Journal of endocrinology, 2004, Volume: 182, Issue:1

    Topics: Activins; Animals; Bacterial Infections; Cyclooxygenase Inhibitors; Female; Flurbiprofen; Follistatin; Inhibin-beta Subunits; Injections, Intravenous; Interleukin-6; Lipopolysaccharides; Sheep; Sheep Diseases; Time Factors; Tumor Necrosis Factor-alpha

2004
[Current approaches to the prevention of infectious complications in heart surgery].
    Khirurgiia, 1993, Issue:2

    Topics: Activins; Adjuvants, Immunologic; Adolescent; Adult; B-Lymphocytes; Bacterial Infections; Cefotaxime; Extracorporeal Circulation; Heart Valve Diseases; Humans; Intraoperative Complications; Middle Aged; Oligopeptides; Peptides; Pneumonia; Postoperative Care; Rheumatic Heart Disease; Risk Factors; Surgical Wound Infection; T-Lymphocytes

1993